Literature DB >> 1173232

Minocycline: A review of its antibacterial and pharmacokinetic properties and therapeutic use.

R N Brogden, T M Speight, G S Avery.   

Abstract

Minocycline is a semi-synthetic tetracycline derivative which is well absorbed and distributed in body tissues and is suitable for twice daily administration. It appears to be as generally effective as other tetracyclines and analogues, but also to be effective in infections due to tetracycline-resistant staphylococci. Side-effects are typical of those of other tetracyclines, but minocycline has been associated with a high incidence of vertigo in some studies. On the other hand, minocycline appears to have little or no photosensitising potential. It is not yet clear whether minocycline can be safely used in patients with moderate or severe impairment of renal function, but if used in renal failure, the plasma urea concentration should be monitored.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1173232     DOI: 10.2165/00003495-197509040-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  83 in total

1.  The excretion and distribution in body fluids of tetracyclines after intravenous administration to dogs.

Authors:  M von WITTENAU; R YEARY
Journal:  J Pharmacol Exp Ther       Date:  1963-05       Impact factor: 4.030

2.  Minocycline in the treatment of cholera. A comparison with tetracycline.

Authors:  D N Mazumder; B K Sirkar; S P De
Journal:  Indian J Med Res       Date:  1974-05       Impact factor: 2.375

3.  Studies on the absorption and excretion of minocycline and a comparison with doxycycline.

Authors:  K Alestig; J Lindberg
Journal:  Infection       Date:  1974       Impact factor: 3.553

4.  Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro.

Authors:  N H Steigbigel; C W Reed; M Finland
Journal:  Am J Med Sci       Date:  1968-03       Impact factor: 2.378

5.  Gonococcal antibiotic resistance in Los Angeles.

Authors:  T F Keys
Journal:  West J Med       Date:  1974-06

6.  [Minocycline].

Authors:  Y Miura; T Mizumoto; H Shibaki
Journal:  Jpn J Antibiot       Date:  1969-12

7.  One-capsule treatment of gonorrhea with minocycline.

Authors:  H Pariser; A F Marino
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

8.  Treatment of chronic staphylococcal osteomyelitis with minocycline hydrochloride: a case report.

Authors:  R E Preininger
Journal:  Curr Ther Res Clin Exp       Date:  1973-08

9.  Treatment of gonorrhoea with a single oral dose of minocycline.

Authors:  W C Duncan; J M Glicksman; J M Knox; W R Holder
Journal:  Br J Vener Dis       Date:  1971-10

10.  [Evaluation of minocycline (7-dimethylamino-6-demethyl-6-deoxytetracycline) in the dermatological field].

Authors:  M Goto
Journal:  Jpn J Antibiot       Date:  1969-12
View more
  28 in total

Review 1.  Antibiotics and breast-feeding: a critical review of the literature.

Authors:  Allison M Chung; Michael D Reed; Jeffrey L Blumer
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

2.  Minocycline reduces spontaneous hemorrhage in mouse models of cerebral amyloid angiopathy.

Authors:  Ping Yan; Alec Zhu; Fan Liao; Qingli Xiao; Andrew Kraft; Ernie Gonzales; Ron Perez; Steven M Greenberg; David Holtzman; Jin-Moo Lee
Journal:  Stroke       Date:  2015-05-05       Impact factor: 7.914

Review 3.  Guide to drug dosage in renal failure.

Authors:  W M Bennett
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

4.  Side effects of minocycline: different dosage regimens.

Authors:  D W Gump; T Ashikaga; T J Fink; A M Radin
Journal:  Antimicrob Agents Chemother       Date:  1977-11       Impact factor: 5.191

5.  Brain microglial cytokines in neurogenic hypertension.

Authors:  Peng Shi; Carlos Diez-Freire; Joo Yun Jun; Yanfei Qi; Michael J Katovich; Qiuhong Li; Srinivas Sriramula; Joseph Francis; Colin Sumners; Mohan K Raizada
Journal:  Hypertension       Date:  2010-06-14       Impact factor: 10.190

6.  Kinetics of the actions of tetracyclines on Escherichia coli as studied by microcalorimetry.

Authors:  P Mardh; T Ripa; K Andersson; I Wadso
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

7.  Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial.

Authors:  N Sacktor; S Miyahara; L Deng; S Evans; G Schifitto; B A Cohen; R Paul; K Robertson; B Jarocki; K Scarsi; R W Coombs; M C Zink; A Nath; E Smith; R J Ellis; E Singer; J Weihe; S McCarthy; L Hosey; D B Clifford
Journal:  Neurology       Date:  2011-09-07       Impact factor: 9.910

Review 8.  Minocycline: far beyond an antibiotic.

Authors:  N Garrido-Mesa; A Zarzuelo; J Gálvez
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

9.  Combination of minocycline and rifampicin against methicillin- and gentamicin-resistant Staphylococcus aureus.

Authors:  E Yourassowsky; M P van der Linden; M J Lismont; F Crokaert
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

10.  Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment.

Authors:  Noeline Nakasujja; Sachiko Miyahara; Scott Evans; Anthony Lee; Seggane Musisi; Elly Katabira; Kevin Robertson; Allan Ronald; David B Clifford; Ned Sacktor
Journal:  Neurology       Date:  2012-12-26       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.